Liver Biopsy Market to Soar to $9.25 Billion by 2031, Fueled by Rising Alcohol and Obesity-Related Liver Issues
The Liver Biopsy Market, valued at USD 5,505.71 million in 2023, is projected to grow significantly to USD 9,249.79 million by 2031, reflecting a robust compound annual growth rate (CAGR) of 6.7% during the forecast period from 2024 to 2031. This growth is driven by increasing incidences of liver diseases worldwide, prompting higher demand for diagnostic procedures like liver biopsies.
The global Liver Biopsy Market, valued at USD 5,505.71 million in 2023, is projected to reach USD 9,249.79 million by 2031, with a steady compound annual growth rate (CAGR) of 6.7% during the forecast period from 2024 to 2031. This growth is driven by increasing incidences of liver diseases worldwide and advancements in biopsy techniques.
Download Free Sample Report of Chromatography Software Market @ www.snsinsider.com/sample-request/2796
Market Dynamics
The Liver Biopsy Market is experiencing significant growth due to:
- Rising Liver Diseases: Increasing prevalence of liver disorders such as hepatitis, cirrhosis, and fatty liver disease is driving the demand for accurate diagnostic tools like liver biopsy.
- Technological Advancements: Continuous improvements in biopsy techniques, including minimally invasive procedures and imaging-guided biopsies, enhancing safety and accuracy.
- Growing Healthcare Expenditure: Rising healthcare expenditure, particularly in developing regions, supporting the adoption of advanced diagnostic procedures for liver diseases.
Key Segments
- By Type: Covers percutaneous biopsy, transjugular biopsy, and laparoscopic biopsy, among others, each offering specific advantages depending on patient condition and diagnostic requirements.
- By End-user: Includes hospitals, diagnostic centers, and specialty clinics where liver biopsies are performed to diagnose and monitor liver diseases effectively.
Regional Insights
- North America: Dominates the Liver Biopsy Market owing to the high prevalence of liver diseases, well-established healthcare infrastructure, and early adoption of advanced medical technologies.
- Europe: Follows with significant investments in healthcare and research, along with increasing awareness about liver diseases and their diagnostic methods.
- Asia Pacific: Represents a rapidly growing market driven by improving healthcare facilities, rising disposable incomes, and increasing government initiatives to improve healthcare access and quality.
Competitive Landscape
The Liver Biopsy Market is competitive with key players focusing on product innovations, strategic collaborations, and geographical expansion to strengthen their market presence.
Key Players
Prominent companies in the Liver Biopsy Market include:
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cook Medical
- Olympus Corporation
- Argon Medical Devices, Inc.
- Cardinal Health, Inc.
- Medtronic plc
- Hologic, Inc.
- Fujifilm Holdings Corporation
- Danaher Corporation (Beckman Coulter)
Make Enquiry About Liver Biopsy Market Report: www.snsinsider.com/enquiry/2796
Table of Content
Chapter 1 Introduction
Chapter 2 Research Methodology
Chapter 3 Liver Biopsy Market Dynamics
Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)
Chapter 5 Value Chain Analysis
Chapter 6 Porter’s 5 forces model
Chapter 7 PEST Analysis
Chapter 8 Liver Biopsy Market Segmentation, By Product
Chapter 9 Liver Biopsy Market Segmentation, By Technology
Chapter 10 Liver Biopsy Market Segmentation, By Application
Chapter 11 Liver Biopsy Market Segmentation, By End User
Chapter 12 Liver Biopsy Market – Regional Analysis
Chapter 13 Company profile
Chapter 14 Competitive Landscape
Chapter 15 Use Case and Best Practices
Chapter 16 Conclusion
Access This Full Report with Charts And Graphs @ www.snsinsider.com/reports…arket-2796
News From
SNS Insider PVT LTDCategory: Industry Reports & Market Analysis Profile: In the fast-paced business biospheres, businesses need to constantly evolve to grow and stay relevant. At SNS Insider, we believe in adopting a data-oriented approach to aid organizations be familiar with the nerve of the industry.
This email address is being protected from spambots. You need JavaScript enabled to view it.
link
